U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07144852) titled 'Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities' on Aug. 20.
Brief Summary: This Phase 3, randomized, multi-center, evaluator-blind, vehicle-controlled study evaluates the efficacy and safety of reformulated Levulan Kerastick (aminolevulinic acid HCl 20%) combined with photodynamic therapy (PDT) for field-directed treatment of actinic keratosis (AK) on the upper extremities. Approximately 260 adult patients with 4-8 mild to moderate AK lesions on one arm will be randomized to receive either active treatment or vehicle control, followed by exposure to blue light. During the study, up to 2 P...